Professor Timo Müller

Timo Müller Recognized as a Highly Cited Researcher 2026

Awards & Grants Diabetes IDO

Prof. Timo Müller, Director of the Institute for Diabetes and Obesity at Helmholtz Munich, has been named a Highly Cited Researcher 2026 by Clarivate. This international recognition honors researchers whose scientific publications are highly cited and have a significant impact on their respective fields.

See more from Helmholtz Munich on Google. Activate

Clarivate has included Timo Müller in this year’s list of Highly Cited Researchers. The Director of the Institute for Diabetes and Obesity (IDO) is recognized in the Cross-Field category.

Research on Obesity and Diabetes

Müller's research focuses on developing new pharmacological treatments for obesity and diabetes. A particular emphasis is placed on investigating metabolic hormones such as GLP-1 and GIP and their potential for treating these conditions.

“Hormone-based therapeutics have fundamentally transformed the treatment of metabolic diseases in recent years. I am very pleased that our work is contributing to this progress,” says Timo Müller.

About the Highly Cited Researchers

The annual Highly Cited Researchers list recognizes scientists who have demonstrated significant influence in their respective research fields. The selection is based, among other criteria, on publications that rank among the top 1% most cited worldwide in their respective fields and publication years. Clarivate also considers additional quantitative and qualitative criteria in its evaluation.

Further Information

Timo Müller – Researcher Profile at Helmholtz Munich

Highly Cited Researchers – Clarivate 

Professor Timo Müller
Prof. Dr. Timo Müller

Institute Director, Head of Research Unit Molecular Pharmacology, IDO

View profile

Related news

Professor Timo Müller

Awards & Grants, Diabetes, IDO,

Timo Müller Receives 2026 Gill Transformative Investigator Award

Timo Müller, Director of the Institute for Diabetes and Obesity (IDO) at Helmholtz Munich and Professor at Ludwig-Maximilians-Universität München (LMU), has received the 2026 Gill Transformative Investigator Award. With this distinction, the Gill…

Read more

Professor Timo Müller

Awards & Grants, Diabetes, IDO,

Timo Müller Receives the ADA 2026 Outstanding Scientific Achievement Award

The American Diabetes Association (ADA) has announced the recipients of this year's National Scientific and Health Care Achievement Awards. Among this year’s awardees is Prof. Timo Müller, Director of the Institute for Diabetes and Obesity (IDO) at…

Read more